REFERENCES

1. Curhan GC, Speizer FE, Hunter DJ, Curchan SG, Stampfer MJ. Epidemiology of interstitial cystitis: a population based study. J Urol 1999;161:549-52.

2. Teichman JM, Moldwin R. The role of the bladder surface in interstitial cystitis/painful bladder syndrome. Can J Urol 2007;14:3599-607.

3. Fall M, Johansson SL, Aldenborg F. Chronic interstitial cystitis: a heterogeneous syndrome. J Urol 1987;137:35-8.

4. American Urological Association (AUA) treatment guidelines 2011. Available from: http://www.auanet.org/guidelines [Last accessed on 4 Dec 2017].

5. Mankad PS, Codispoti M. The role of fibrin sealants in hemostasis. Am J Surg 2001;182:S21-8.

6. Jackson MR. Fibrin sealants in surgical practice: an overview. Am J Surg 2001;182:S1-7.

7. Schwartz M, Madariaga J, Hirose R, Shaver TR, Sher L, Chari R, Colonna JO 2nd, Heaton N, Mirza D, Adams R, Rees M, Lloyd D. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 2004;139:1148-54.

8. Fattahi T, Mohan M, Caldwell GT. Clinical applications of fibrin sealants. J Oral Maxillofac Surg 2004;62:218-24.

9. Hong YM, Loughlin KR. The use of hemostatic agents and sealants in urology. J Urol 2006;176:2367-74.

10. Serrano Frago P, Allepuz Losa C, Gil Martínez P, Allué López M, Mallén Mateo E, Sancho Serrano C, Rioja Sanz LA. Treatment of hemorrhagic cystitis secondary to cyclophosphamide. Literature review with regard to a case. Actas Urol Esp 2005;29:230-3. (in Spanish)

11. O'Leary MP, Barry MJ, Fowler FJ, Jr. Hard measures of subjective outcomes: validating symptom indexes in urology. J Uro1 1992;148:1546-8, discussion 1564.

12. Keller ML, McCarthy DO, Neider RS. Measurement of symptoms of interstitial cystitis. A pilot study. Urol Clin North Am 1994;21:67-71.

13. Kleinbaum DG, Kupper LL, Morgenstem H. Epidemiologic Research: Principles and Quantitative Methods New York: Lifetime Learning Publications; 1982. p. 152.

14. Deyo RH, Diehr P, Patrick D. Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. Controlled Clin Trials 1991;12:S142-58.

15. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297A.

16. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG; Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. N Engl J Med 1995;332:75-9.

17. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.

18. Apolone G, Mosconi P, Ware JE. Questionario sullo stato di salute SF-36. Manuale d'uso e guida all'interpretazione dei risultati. Milano: Guerini e associati; 1997.

19. Dodd RA, Cornwell R, Holm NE, Garbarsch A, Hollingsbee DA. The Vivostat application system: a comparison with conventional fibrin sealant application systems. Technol Health Care 2002;10:401-11.

20. Srikrishna S, Robinson D, Cardozo L. Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse. Int Urogynecol J 2010;21:523-8.

21. Diokno AC, Homma Y, Sekiguchi Y, Suzuki Y. Interstitial cystitis, gynecologic pelvic pain, prostatitis, and their epidemiology. Int J Urol 2003;10:S3-6.

22. Offiah I, McMahon SB, O'Reilly BA. Interstitial cystitis/bladder pain syndrome: diagnosis and management. Int Urogynecol J 2013;24:1243-56.

23. van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, Elneil S, Fall M, Hohlbrugger G, Irwin P, Mortensen S, van Ophoven A, Osborne JL, Peeker R, Richter B, Riedl C, Sairanen J, Tinzl M, Wyndaele JJ. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 2008;53:60-7.

24. Hunner GL. A rare type of bladder ulcer in women: report of cases. Trans South Surg Gynecol Assoc 1914;27:247-92.

25. Johansson SL, Fall M. Clinical features and spectrum of light microscopic changes in interstitial cystitis. J Urol 1990;143:1118-24.

26. Lamm DL, Gittes RF. Inflammatory carcinoma of the bladder and interstitial cystitis. J Urol 1977;117:49-51.

27. Tirindelli MC, Flammia G, Sergi F, Cerretti R, Cudillo L, Picardi A, Postorino M, Annibali O, Greco R, Avvisati G, Arcese W. Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation. Transfusion 2009;49:170-5.

28. Cheng L, Lopez-Beltran A, Bostwick DG. Bladder pathology. In: Interstitial cystitis. Hoboken (NJ): Wiley-Blackwell; 2012. pp. 22-5.

29. Lynes WL, Flynn SD, Shortliffe LD, Stamey TA. The histology of interstitial cystitis. Am J Surg Pathol 1990;14:969-76.

30. Kim HJ. Update on the pathology and diagnosis of interstitial cystitis/bladder pain syndrome: a review. Int Neurourol J 2016;20:13-7.

31. American Urological Association (AUA) treatment guidelines 2016. Available from: http://www.auanet.org/guidelines [Last accessed on 4 Dec 2017].